CorMedix Inc.

NASDAQ: CRMD · Real-Time Price · USD
12.91
0.30 (2.38%)
At close: Aug 15, 2025, 3:59 PM
12.93
0.15%
After-hours: Aug 15, 2025, 07:54 PM EDT

CorMedix Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
39.74M 39.08M 31.21M 11.46M 806.12K n/a 304.11K n/a n/a n/a 29.7K 6.82K 21.25K 7.64K 56.4K 38.09K 8.19K 88.26K
Cost of Revenue
1.86M 1.6M 1.18M 686.6K 509.84K 818.54K 53.51K 51.86K 50.75K 49.45K 406.00 1.47K 332.00 1.53K 48.01K 25.17K 14.43K 61.34K
Gross Profit
37.87M 37.48M 30.03M 10.77M 296.28K -818.54K 250.6K -51.86K -50.75K -49.45K 29.3K 5.35K 20.92K 6.11K 8.39K 12.92K -6.24K 26.92K
Operating Income
19.54M 20.13M 12.94M -3.29M -15.3M -16.7M -15.67M -10.47M -11.8M -11.02M -8.39M -6.96M -8.24M -7.03M -7.78M -8.56M -5.88M -7.21M
Interest Income
828.95K 566.8K 510.38K 553.86K 657.37K 857.19K 920.04K 765.24K 550.18K 446.38K 183.51K 93.42K 35.34K 13.75K 4.37K 3.02K 3.34K 3.67K
Pretax Income
20.35M 20.64M 13.46M -2.78M -14.15M -15.86M -14.75M -9.74M -11.27M -10.57M -8.21M -6.85M -8.19M -7.03M -7.79M -8.57M -5.88M -7.22M
Net Income
19.83M 20.64M 13.46M -2.78M -14.15M -14.47M -14.75M -9.74M -11.27M 430.61M -8.03M -6.75M -7.6M -7.04M -7.79M -8.57M -4.63M -7.22M
Selling & General & Admin
3.12B 14.17M 15.37M 13.33M 14.95M 15.05M 13.33M 7.8M 7.01M 7.61M 5.58M 4.63M 5.05M 4.75M 4.55M 3.84M 3.36M 4.6M
Research & Development
2.44B 3.19M 1.73M 727.12K 650.99K 837.45K 2.29M 2.66M 4.79M 3.41M 2.84M 2.34M 3.21M 2.29M 3.24M 4.74M 2.52M 2.64M
Other Expenses
-5.54B n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
18.33M 17.36M 17.1M 14.06M 15.6M 15.89M 15.62M 10.47M 11.8M 11.02M 8.42M 6.97M 8.26M 7.04M 7.79M 8.58M 5.88M 7.24M
Interest Expense
6.67K 10.01K 10.01K 10.01K 6.56K 9.84K 6.56K 13.11K 5.85K 8.78K 8.78K 8.78K 3.58K 5.38K 5.38K 5.38K n/a 5.18K
Selling & Marketing Expenses
-6.38B 4.47M 8.26M 6.75M 7.39M 6.34M 8.16M 4.06M 3.26M n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
20.19M 18.96M 18.27M 14.74M 16.11M 16.7M 15.67M 10.47M 11.8M 11.02M 8.42M 6.97M 8.26M 7.04M 7.79M 8.6M 5.89M 7.3M
Income Tax Expense
521.51K n/a n/a n/a n/a -1.39M 3.00 n/a -17.43K -441.18M -180.28K -108.21K -585.62K 1.83K 5.38K 5.38K -1.25M 5.18K
Shares Outstanding (Basic)
67.93M 65.24M 61.51M 58.83M 57.62M 57.5M 57.39M 56.55M 45.37M 44.03M 41.18M 40.32M 39.76M 38.25M 37.16M 38.11M 38.08M 36.33M
Shares Outstanding (Diluted)
71.92M 68.98M 61.51M 58.83M 57.62M 57.5M 57.39M 56.55M 45.37M 44.09M 41.86M 41.18M 39.76M 38.25M 38.11M 38.11M 38.08M 36.33M
EPS (Basic)
0.29 0.32 0.22 -0.05 -0.25 -0.25 -0.26 -0.17 -0.25 9.78 -0.19 -0.17 -0.19 -0.18 -0.21 -0.22 -0.12 -0.2
EPS (Diluted)
0.28 0.30 0.22 -0.05 -0.25 -0.25 -0.26 -0.17 -0.25 9.77 -0.19 -0.16 -0.19 -0.18 -0.2 -0.22 -0.12 -0.2
EBITDA
20.52M 20.82M 13.65M -2.65M -14.03M -15.79M -14.7M -9.68M -11.22M -10.51M -8.15M -6.79M -8.14M -7.01M -7.76M -8.54M -5.87M -7.2M
EBIT
20.36M 20.65M 13.47M -2.77M -14.14M -15.85M -14.75M -9.73M -11.27M -10.56M -8.2M -6.84M -8.19M -7.03M -7.79M -8.56M -5.88M -7.21M
Depreciation & Amortization
162.94K 161.94K 171.84K 114.71K 113.34K 57.47K 53.51K 51.86K 50.75K 49.45K 54.38K 52.46K 51.59K 50.61K 130.13K 19.25K 13.97K 13.68K